ITOX 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-07-09

• We regularly review the carrying value and estimated lives of its long-lived assets to determine whether indicators of impairment may exist that warrant adjustments to the carrying value or estimated useful lives. The determinants used for this evaluation include management’s estimate of the asset’s…

• When we issue convertible debt or convertible preferred stock, we first evaluate the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480, Distinguishing Liabilities from Equity, and second wh…

• On October 30, 2025, we had a change of control in management, and the Company and its debtholders mutually agreed to convert their convertible promissory notes due, and compensation due to officers in exchange for issuance of Series E Preferred Stock in full settlement of all balances due.

• For the three months ended March 31, 2025, we did not record any revenues and related cost of sales. Our operating expenses totaled $92,258 which included payroll costs of $50,000, amortization of intangible assets of $12,205, and general and administrative expenses of $30,053. We recorded net other…

• No revenues were earned in Q1, 2026, as in prior year quarter ending March 31, 2025. We believe revenue growth for the rest of 2026 will be challenging given the difficulty in raising additional capital to fuel sales and marketing efforts. Potential future revenue growth depends on our ability to ra…

相对上期删除的文字 · 来源:10-Q · 2025-12-12

• For the three months ended September 30, 2024, we did not earn any revenues and did not incur related cost of sales. Our operating expenses were $155,831 which included payroll costs of $50,000, amortization of intangible assets of $12,477, legal and professional fees of $84,279, and general and adm…

• Results of Operations for the Nine Months Ended September 30, 2025 Compared to the Nine Months Ended September 30, 2024 (Unaudited)

• For the nine months ended September 30, 2025, we did not earn any revenue and did not incur related cost of sales. Our operating expenses were $313,264 which included payroll costs of $150,000, amortization of intangible assets of $37,022, legal and professional fees of $108,381, and general and adm…

• For the nine months ended September 30, 2024, we earned revenues of $2,500 and recorded related cost of sales of $2,125. Our operating expenses were $327,186 which included payroll costs of $150,518, amortization of intangible assets of $37,159, legal and professional fees of $129,325, and general a…

• During the current and prior period, we did not record an income tax benefit due to the uncertainty associated with the Company’s ability to utilize the deferred tax assets.